259 related articles for article (PubMed ID: 17766391)
1. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
2. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.
Frelin C; Imbert V; Bottero V; Gonthier N; Samraj AK; Schulze-Osthoff K; Auberger P; Courtois G; Peyron JF
Cell Death Differ; 2008 Jan; 15(1):152-60. PubMed ID: 17932497
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
[TBL] [Abstract][Full Text] [Related]
6. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.
Agou F; Courtois G; Chiaravalli J; Baleux F; Coïc YM; Traincard F; Israël A; Véron M
J Biol Chem; 2004 Dec; 279(52):54248-57. PubMed ID: 15466857
[TBL] [Abstract][Full Text] [Related]
9. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
Wagner S; Carpentier I; Rogov V; Kreike M; Ikeda F; Löhr F; Wu CJ; Ashwell JD; Dötsch V; Dikic I; Beyaert R
Oncogene; 2008 Jun; 27(26):3739-45. PubMed ID: 18212736
[TBL] [Abstract][Full Text] [Related]
11. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A
Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
13. The influence of the signal dynamics of activated form of IKK on NF-kappaB and anti-apoptotic gene expressions: a systems biology approach.
Park SG; Lee T; Kang HY; Park K; Cho KH; Jung G
FEBS Lett; 2006 Feb; 580(3):822-30. PubMed ID: 16413545
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
Shifera AS
J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
[TBL] [Abstract][Full Text] [Related]
15. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
16. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization.
Tas SW; de Jong EC; Hajji N; May MJ; Ghosh S; Vervoordeldonk MJ; Tak PP
Eur J Immunol; 2005 Apr; 35(4):1164-74. PubMed ID: 15770694
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.
Sebban H; Yamaoka S; Courtois G
Trends Cell Biol; 2006 Nov; 16(11):569-77. PubMed ID: 16987664
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
